Founded to revolutionize respiratory health monitoring, Clairways focuses on providing smart lung monitoring solutions specifically tailored for pharmaceutical clinical trials. Their core mission is to enhance the accuracy and efficiency of respiratory data collection through innovative technology. Clairways offers a unique AI-powered smart pendant that enables long-term, continuous, and privacy-preserving lung monitoring, reducing the reliance on effort-dependent methods and improving both compliance and data quality.

Notable affiliated people and investors in Clairways include experts in respiratory health and technology innovation, though specific names are not provided. Key achievements include the development of their unobtrusive smart pendant and the successful integration of AI to deliver comprehensive respiratory health insights. Clairways has significantly impacted the field of clinical trials by providing a more reliable and user-friendly method for lung monitoring, ultimately aiming to improve patient outcomes and streamline pharmaceutical research.